JavaScript is disabled for your browser. Some features of this site may not work without it.
Система будет остановлена для регулярного обслуживания. Пожалуйста, сохраните рабочие данные и выйдите из системы.
Статистика
Жалпы қатысу саны
| Көру | |
|---|---|
| SUSTAINED DELIVERY OF A MONOCLONAL ANTIBODY AGAINST SARS-COV-2 BY MICROENCAPSULATED CELLS: A PROOF-OF-CONCEPT STUDY | 114 |
Бір айдағы саны
| January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | |
|---|---|---|---|---|---|---|---|
| SUSTAINED DELIVERY OF A MONOCLONAL ANTIBODY AGAINST SARS-COV-2 BY MICROENCAPSULATED CELLS: A PROOF-OF-CONCEPT STUDY | 6 | 38 | 7 | 11 | 5 | 6 | 1 |
Файлдарға жүгіну
| Көру | |
|---|---|
| pharmaceutics-14-02042-v3.pdf | 21 |
елдер бойынша
| Көру | |
|---|---|
| United States | 92 |
| Russia | 7 |
| Australia | 3 |
| China | 3 |
| Sweden | 3 |
| Kazakhstan | 2 |
| Germany | 1 |
| Turkey | 1 |
қалалар бойынша
| Көру | |
|---|---|
| San Mateo | 40 |
| Boardman | 12 |
| Oakland | 12 |
| Moscow | 7 |
| Itasca | 4 |
| Ann Arbor | 3 |
| Fremont | 3 |
| Andover | 2 |
| Ashburn | 2 |
| Louisville | 2 |
Ұсыну нұсқаулығы